| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.22 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |